D. Koenig

Novel polymorphisms associated with hyperalphalipoproteinemia and apparent cardioprotection.

J. O’Connell, B. Mitchell, Michael Miller, 2017, Journal of clinical lipidology.

Correspondence on “SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response” by Bonelli et al

A. Azar, P. Seo, D. Geetha, 2021, Annals of the Rheumatic Diseases.

Novel Polymorphisms Associated with Hyperalphalipoproteinemia (HALP) and Apparent Cardioprotection

B. Mitchell, Michael Miller, J. Rhyne, 2018 .